Plasma Metabolite Associations for Risk and Laboratory Measures of Type 2 Diabetes in a Large-Scale Finnish Prospective Cohort
This study identifies T2D plasma metabolic biomarkers for further investigation in women and other populations. The findings enhance our understanding of T2D biology.
Authors
- Xinxian Hu
- Lilian Fernandes Silva (ORCID: https://orcid.org/0000-0003-0225-842X)
- M. Laakso
- Erin N. Smith (ORCID: https://orcid.org/0000-0001-9632-4760)
- Qi Fu (ORCID: https://orcid.org/0000-0002-5731-7186)
- Charles Burant (ORCID: https://orcid.org/0000-0001-9189-5003)
- Dan L. Ciotlos (ORCID: https://orcid.org/0000-0003-2421-6650)
- Wen Xiaoquan
- Xiaomeng Chu
- Taoyue Yang
- Ruyi Peng
- Jean Morrison
- Xiaolong Ji
- Zhijie Xia
- Jack Li
- Xianyong Yin
- Heather M. Stringham
- Lei Liu
- Yuxi Liang
Institutions
- Target (United States) (US)
- University of Eastern Finland (FI)
- Pfizer (United States) (US)
- University of Michigan (US)
- Michigan Medicine (US)
- Statistical Service (CY)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Diabetes Care
- Published
- 2026-02-04
- DOI
- https://doi.org/10.2337/dc25-2201
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Diabetes Association
- Pfizer
- National Natural Science Foundation of China
- Nanjing Medical University
- National Science and Technology Major Project
- National Institutes of Health